BioAmber Inc. announced that Ellen Richstone and Henry Pete Linsert, Jr. were elected to company's board of directors at the Annual Meeting of Shareholders held on May 27, 2014. Ms. Richstone and Mr. Linsert were elected by company's stockholders as Class I directors, each to hold office until the 2017 annual meeting of stockholders. Ms. Richstone will serve on the Nominating and Corporate Governance Committee and the Audit Committee, and was designated by the Board as an audit committee financial expert.

Mr. Linsert will serve on the Compensation Committee. Ms. Richstone was the Chief Financial Officer of several public and private companies between 1989 and 2012, including Rohr Aerospace. Currently, she serves on the corporate advisory boards of Paxeramed, a medical device company, and Pro Teck Valuation Services, and on the boards of non-profit organizations Employment Resources Inc. and the National Association of Corporate Directors-New England.

Mr. Linsert currently serves on the review committee of the U.S. National Academies of Sciences for Technology, Innovation and Entrepreneurship. Mr. Linsert was the Chairman of the Board and Chief Executive Officer of Martek Biosciences Corporation from 1989 to 2006.